Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

BTG licenses peptide technology to CeNeS

Nov. 19, 1997

Dainippon develops sustained-release morphine preparation

Nov. 18, 1997

Warner-Lambert describes novel anticonvulsants related to gabapentin

Nov. 18, 1997

New antidepressant and cognition enhancer developed in Russia

Nov. 17, 1997

Anesta's Actiq denied FDA approval

Nov. 17, 1997

Anticonvulsants with reduced side effects from RCT

Nov. 17, 1997

Brain GABA-A receptor ligands prepared at Neurogen

Nov. 17, 1997

Aradigm tests inhalation form of morphine in volunteers

Nov. 14, 1997

nNOS inhibitor from Astra effective in animal models of stroke, ALS

Nov. 14, 1997

Roche in-licenses promising antiparkinsonian agent

Nov. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...